• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 7 of 24

 
<< Start < Prev 2 3 4 5 6 7 8 9 10 11Next >End >>
04.06.2020 Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy

Press Release

04.06.2020 Axonics® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology

Press Release

21.05.2020Amphista Therapeutics appoints leading protein degradation pioneer, Ian Churcher as CSO

Press Release

13.05.2020Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team

Press Release

23.04.2020Nalu Medical, Inc. Appoints New Chief Executive Officer: Earl R. Fender Joins as President & CEO

Press Release

20.04.2020 Zikani Therapeutics Completes Series A-1 Funding

Press Release

17.04.2020Highlight Therapeutics announces name change from Bioncotech and launch of new website

Press Release

17.04.2020Highlight Therapeutics appoints Dr. Carlos Paya as Executive Chairman

Press Release

15.04.2020Advent Life Sciences Continues Support of Innovation in Life Sciences with the Launch of Two New Cancer Companies

Press Release

15.04.2020PIC Therapeutics Raises $5 Million to Advance Development of Small Molecules That Selectively Modulate eIF4E

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences